Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
57%(4 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
1
10%
Ph phase_3
1
10%
Ph phase_4
5
50%
Ph not_applicable
2
20%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
5(55.6%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 45 (55.6%)
N/A2 (22.2%)

Trials by Status

completed770%
terminated110%
withdrawn110%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10